Proton beam therapy is an advanced form of external radiotherapy that uses high energy proton beams instead of photon x ray beams or electrons.
Proton beam therapy for glioblastoma uk.
Proton beam therapy pbt has been available to uk patients since 2008 through the nhs funded overseas programme and the clatterbridge cancer centre has treated patients with rare eye cancers with low energy protons for many years.
Up until very recently everyone needing high energy proton beam therapy had to go abroad for treatment.
In 2009 the uk government made the decision to set up a national nhs proton beam therapy service.
It is used to help reduce the risk of long term side effects that can sometimes develop after standard radiotherapy.
Proton beam therapy pbt is a type of radiotherapy that uses beams of protons energised particles instead of beams of x rays photons that are used in conventional radiotherapy.
It is more targeted than conventional radiotherapy so does less damage to the healthy tissue around the tumour and in the rest of the brain.
There are also other new discoveries in adult and childhood brain cancer research and treatment.
The guide to proton beam therapy this information is written for you in 10 easy to understand sections to be used individually or as a complete set.
The government committed 250 million capital investment for both nhs proton beam therapy centres.
Developing the uk proton beam therapy service.
Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive.
As of july 2020 this now includes an online faqs guide.
Both trusts have more information about the new proton beam therapy centres on their.
Proton beam therapy is a type of external beam radiotherapy.
A ground breaking clinical trial is treating glioblastoma with intensity modulated proton therapy impt.
Carefully measured doses of protons are delivered to the precise area needing treatment using the latest iba proteusone technology.
Proton beam therapy is only suitable for a small number of people.